Nevro Pocfratio vs Capex To Depreciation Analysis

NVRO Stock

USD 5.72 0.70 13.94%

Nevro Corp financial indicator trend analysis is infinitely more than just investigating Nevro Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nevro Corp is a good investment. Please check the relationship between Nevro Corp Pocfratio and its Capex To Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Pocfratio vs Capex To Depreciation

Pocfratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nevro Corp Pocfratio account and Capex To Depreciation. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Nevro Corp's Pocfratio and Capex To Depreciation is -0.14. Overlapping area represents the amount of variation of Pocfratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Nevro Corp, assuming nothing else is changed. The correlation between historical values of Nevro Corp's Pocfratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pocfratio of Nevro Corp are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Pocfratio i.e., Nevro Corp's Pocfratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

-0.14

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Pocfratio

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Nevro Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nevro Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.At this time, Nevro Corp's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 7th of February 2025, Enterprise Value is likely to grow to about 1.5 B, while Selling General Administrative is likely to drop about 215.3 M.

	2022	2023	2024	2025 (projected)
Gross Profit	276.4M	290.1M	333.6M	191.8M
Total Revenue	406.4M	425.2M	489.0M	280.2M

Gross Profit Total Revenue

Nevro Corp fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.92	0.85	0.97	0.38	0.85	0.86	-0.89	0.89	0.69	0.66	0.63	0.5	0.96	0.93	0.92	0.95	0.89	0.86	0.92	0.88	0.97	0.98	0.72	0.99	0.92
Other Current Liab	0.92		0.67	0.85	0.37	0.87	0.77	-0.89	0.84	0.7	0.72	0.82	0.4	0.8	0.98	0.87	0.93	0.69	0.9	0.96	0.94	0.94	0.95	0.76	0.9	0.87
Total Current Liabilities	0.85	0.67		0.81	0.28	0.68	0.91	-0.66	0.66	0.39	0.44	0.43	0.78	0.92	0.71	0.66	0.69	0.93	0.58	0.61	0.65	0.74	0.84	0.5	0.87	0.66
Total Stockholder Equity	0.97	0.85	0.81		0.38	0.79	0.77	-0.83	0.92	0.7	0.58	0.54	0.48	0.97	0.87	0.96	0.94	0.9	0.79	0.89	0.8	0.93	0.91	0.64	0.98	0.96
Other Liab	0.38	0.37	0.28	0.38		0.5	0.37	-0.49	0.57	0.03	0.21	0.2	0.15	0.39	0.36	0.36	0.39	0.44	0.34	0.33	0.1	0.45	0.36	0.28	0.39	0.36
Property Plant And Equipment Net	0.85	0.87	0.68	0.79	0.5		0.7	-0.97	0.79	0.76	0.84	0.66	0.34	0.77	0.83	0.75	0.81	0.69	0.91	0.79	0.83	0.9	0.87	0.89	0.82	0.76
Net Debt	0.86	0.77	0.91	0.77	0.37	0.7		-0.69	0.63	0.3	0.48	0.54	0.71	0.87	0.81	0.66	0.71	0.91	0.7	0.69	0.7	0.75	0.89	0.53	0.87	0.66
Retained Earnings	-0.89	-0.89	-0.66	-0.83	-0.49	-0.97	-0.69		-0.84	-0.79	-0.85	-0.58	-0.23	-0.8	-0.85	-0.8	-0.85	-0.7	-0.92	-0.85	-0.84	-0.94	-0.89	-0.9	-0.85	-0.81
Accounts Payable	0.89	0.84	0.66	0.92	0.57	0.79	0.63	-0.84		0.7	0.56	0.57	0.34	0.84	0.86	0.9	0.95	0.75	0.77	0.9	0.73	0.92	0.84	0.62	0.89	0.89
Cash	0.69	0.7	0.39	0.7	0.03	0.76	0.3	-0.79	0.7		0.82	0.5	-0.02	0.57	0.67	0.72	0.75	0.39	0.81	0.76	0.78	0.75	0.65	0.82	0.65	0.73
Non Current Assets Total	0.66	0.72	0.44	0.58	0.21	0.84	0.48	-0.85	0.56	0.82		0.52	-0.04	0.52	0.64	0.58	0.63	0.41	0.9	0.69	0.73	0.73	0.7	0.99	0.6	0.6
Non Currrent Assets Other	0.63	0.82	0.43	0.54	0.2	0.66	0.54	-0.58	0.57	0.5	0.52		0.48	0.49	0.79	0.66	0.7	0.4	0.66	0.72	0.75	0.63	0.67	0.53	0.61	0.66
Other Assets	0.5	0.4	0.78	0.48	0.15	0.34	0.71	-0.23	0.34	-0.02	-0.04	0.48		0.62	0.46	0.39	0.39	0.7	0.17	0.28	0.36	0.35	0.5	0.02	0.55	0.38
Cash And Short Term Investments	0.96	0.8	0.92	0.97	0.39	0.77	0.87	-0.8	0.84	0.57	0.52	0.49	0.62		0.83	0.87	0.86	0.97	0.74	0.8	0.75	0.88	0.92	0.59	0.98	0.87
Net Receivables	0.93	0.98	0.71	0.87	0.36	0.83	0.81	-0.85	0.86	0.67	0.64	0.79	0.46	0.83		0.87	0.94	0.75	0.88	0.95	0.92	0.92	0.95	0.69	0.92	0.87
Common Stock Total Equity	0.92	0.87	0.66	0.96	0.36	0.75	0.66	-0.8	0.9	0.72	0.58	0.66	0.39	0.87	0.87		0.94	0.78	0.79	0.91	0.81	0.9	0.86	0.63	0.92	1.0
Common Stock Shares Outstanding	0.95	0.93	0.69	0.94	0.39	0.81	0.71	-0.85	0.95	0.75	0.63	0.7	0.39	0.86	0.94	0.94		0.76	0.85	0.98	0.87	0.95	0.91	0.68	0.94	0.94
Short Term Investments	0.89	0.69	0.93	0.9	0.44	0.69	0.91	-0.7	0.75	0.39	0.41	0.4	0.7	0.97	0.75	0.78	0.76		0.64	0.68	0.62	0.77	0.85	0.48	0.92	0.78
Non Current Liabilities Total	0.86	0.9	0.58	0.79	0.34	0.91	0.7	-0.92	0.77	0.81	0.9	0.66	0.17	0.74	0.88	0.79	0.85	0.64		0.89	0.86	0.87	0.87	0.92	0.83	0.81
Inventory	0.92	0.96	0.61	0.89	0.33	0.79	0.69	-0.85	0.9	0.76	0.69	0.72	0.28	0.8	0.95	0.91	0.98	0.68	0.89		0.9	0.94	0.91	0.72	0.9	0.91
Other Current Assets	0.88	0.94	0.65	0.8	0.1	0.83	0.7	-0.84	0.73	0.78	0.73	0.75	0.36	0.75	0.92	0.81	0.87	0.62	0.86	0.9		0.9	0.91	0.76	0.85	0.82
Other Stockholder Equity	0.97	0.94	0.74	0.93	0.45	0.9	0.75	-0.94	0.92	0.75	0.73	0.63	0.35	0.88	0.92	0.9	0.95	0.77	0.87	0.94	0.9		0.96	0.78	0.94	0.9
Total Liab	0.98	0.95	0.84	0.91	0.36	0.87	0.89	-0.89	0.84	0.65	0.7	0.67	0.5	0.92	0.95	0.86	0.91	0.85	0.87	0.91	0.91	0.96		0.75	0.97	0.86
Property Plant And Equipment Gross	0.72	0.76	0.5	0.64	0.28	0.89	0.53	-0.9	0.62	0.82	0.99	0.53	0.02	0.59	0.69	0.63	0.68	0.48	0.92	0.72	0.76	0.78	0.75		0.66	0.65
Total Current Assets	0.99	0.9	0.87	0.98	0.39	0.82	0.87	-0.85	0.89	0.65	0.6	0.61	0.55	0.98	0.92	0.92	0.94	0.92	0.83	0.9	0.85	0.94	0.97	0.66		0.92
Common Stock	0.92	0.87	0.66	0.96	0.36	0.76	0.66	-0.81	0.89	0.73	0.6	0.66	0.38	0.87	0.87	1.0	0.94	0.78	0.81	0.91	0.82	0.9	0.86	0.65	0.92

Click cells to compare fundamentals

Nevro Corp Account Relationship Matchups

Nevro Corp fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	789.4M	574.5M	602.4M	635.7M	731.1M	461.8M
Other Current Liab	42.2M	44.5M	45.3M	53.7M	61.7M	34.2M
Total Current Liabilities	239.2M	82.2M	79.2M	83.4M	95.9M	71.3M
Total Stockholder Equity	388.5M	303.6M	323.9M	293.1M	337.1M	255.5M
Other Liab	1.9M	3.3M	22.0M	2.2M	2.5M	3.6M
Property Plant And Equipment Net	31.7M	38.2M	35.7M	33.5M	38.5M	40.5M
Net Debt	282.6M	132.0M	76.8M	117.6M	135.3M	85.6M
Retained Earnings	(492.8M)	(624.2M)	(607.2M)	(699.4M)	(629.5M)	(598.0M)
Accounts Payable	23.1M	32.0M	26.8M	22.5M	25.9M	19.3M
Cash	44.6M	34.7M	120.4M	104.2M	119.8M	125.8M
Non Current Assets Total	36.3M	43.3M	39.5M	104.8M	120.5M	126.5M
Non Currrent Assets Other	4.0M	4.5M	3.2M	5.8M	6.6M	4.5M
Other Assets	22.8M	5.1M	3.8M	1.0	1.15	1.09
Cash And Short Term Investments	588.0M	362.0M	374.4M	322.7M	371.1M	289.0M
Net Receivables	77.7M	70.5M	78.9M	79.4M	91.3M	57.9M
Common Stock Shares Outstanding	33.7M	34.8M	35.5M	36.0M	41.4M	26.7M
Short Term Investments	543.4M	327.3M	254.0M	218.5M	251.3M	230.8M
Liabilities And Stockholders Equity	789.4M	574.5M	602.4M	635.7M	731.1M	461.8M
Non Current Liabilities Total	161.8M	188.7M	199.3M	259.2M	298.1M	313.0M
Inventory	83.3M	93.5M	99.6M	118.7M	136.5M	78.7M
Other Current Assets	8.3M	5.2M	10.0M	10.1M	11.7M	6.7M
Other Stockholder Equity	880.7M	928.1M	934.1M	992.8M	1.1B	588.4M
Total Liab	401.0M	270.9M	278.5M	342.6M	394.0M	206.3M
Property Plant And Equipment Gross	31.7M	38.2M	35.7M	69.2M	79.6M	83.5M
Total Current Assets	753.1M	531.2M	562.9M	530.9M	610.6M	432.0M
Accumulated Other Comprehensive Income	598K	(364K)	(3.1M)	(243K)	(218.7K)	(229.6K)
Property Plant Equipment	11.8M	13.5M	20.7M	22.3M	25.6M	26.9M
Short Long Term Debt Total	327.2M	166.7M	197.2M	221.8M	255.1M	172.5M
Net Tangible Assets	216.4M	388.5M	303.6M	323.9M	372.5M	291.2M
Long Term Debt	141.8M	151.3M	186.9M	211.5M	243.2M	145.9M
Retained Earnings Total Equity	(409.8M)	(492.8M)	(624.2M)	(607.2M)	(546.5M)	(573.8M)
Long Term Debt Total	160.3M	141.8M	151.3M	186.9M	214.9M	136.3M
Capital Surpluse	626.4M	880.7M	928.1M	934.1M	1.1B	686.8M
Non Current Liabilities Other	20.0M	37.4M	12.5M	43.1M	49.6M	52.0M
Short Term Debt	172.7M	4.6M	5.2M	5.7M	5.1M	4.9M
Net Invested Capital	699.0M	454.9M	510.7M	504.6M	580.3M	524.5M
Net Working Capital	513.9M	449.0M	483.7M	447.5M	514.7M	473.0M

When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:

How To Invest In Nevro

Details

Is Nevro Stock a good investment?

Details

What is Nevro Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.87)

Revenue Per Share

11.404

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.09)

Return On Equity

(0.25)

The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nevro Pocfratio vs Capex To Depreciation Analysis

Pocfratio vs Capex To Depreciation

Pocfratio vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Pocfratio

Capex To Depreciation

Nevro Corp fundamental ratios Correlations

Nevro Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nevro Corp fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets
Net Receivables	+ 0.98	Other Current Liab
Total Current Assets	+ 0.98	Total Stockholder Equity

Retained Earnings	- 0.97	Property Plant And Equipment Net
Other Stockholder Equity	- 0.94	Retained Earnings
Non Current Liabilities Total	- 0.92	Retained Earnings
Property Plant And Equipment Gross	- 0.9	Retained Earnings
Total Liab	- 0.89	Retained Earnings
Retained Earnings	- 0.89	Other Current Liab